Skip to content

A Targeted Falls Prevention Program in Rehabilitation In-Patients

A Targeted Falls Prevention Program in Rehabilitation In-Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00973297
Enrollment
100
Registered
2009-09-09
Start date
2009-11-30
Completion date
2010-11-30
Last updated
2009-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Accidental Falls

Keywords

Falls

Brief summary

Falls are a major complication in patients treated in rehabilitation departments, yet studies evaluating different interventions to reduce falls-risk are rare and inconclusive. The aim of the present study is to evaluate the efficacy of a multidisciplinary fall-prevention program to reduce falls and injury in stroke patients treated in a rehabilitation department. All stroke patients consecutively admitted to the department of rehabilitation at Hadassah-Hebrew University Medical Center for a period of one year will be eligible for inclusion. Upon receiving an informed consent subjects will be randomized to the intervention group or the control (convention care) group. There are no exclusion criteria. The Intervention includes group education on risk of falling and safe mobility and transfers; physical therapy of balance training at the patients' bedside twice weekly and medical assessment of medication use (anxiolytics/hypnotics, neuroleptics, antihypertensives and other vasodilators), orthostatic hypotension, urinary frequency/incontinence, delirium and visual problems. Intervention therapy will not be given as an extra time, rather at the same treatment time as the control group. Primary outcomes are rate of falls and related injuries.

Interventions

OTHERMultidisciplinary falls prevention

Group education on falls risk and mobility and transfers safety; Physical therapy at the subjects' bedside consisting of balance training; Medical assessment - medications use (anxiolytics/hypnotics, neuroleptics, antihypertensives, antiarrhythmics and other vasodilators) with effort to discontinue or reduce dose when possible; orthostatic hypotension - discontinue/reduce dose of related medications; urinary frequency/incontinence - evaluation and treatment; delirium - evaluation and treatment; visual pathology - evaluation and treatment

Sponsors

Hadassah Medical Organization
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All stroke patients admitted to rehabilitation

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
Rate of falls and fall-related injuryAt one year

Countries

Israel

Contacts

Primary ContactYoram Maaravi, MD
ymaaravi@gmail.com00 972 2 5844474

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026